Liming Chen

Fujian University of Traditional Chinese Medicine — China

Medicine · Health Sciences

42h-index7.8kcitations279works4.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Treatment and Management(41), Metabolism, Diabetes, and Cancer(39), Liver Disease Diagnosis and Treatment(31), Pancreatic function and diabetes(28), Diabetes Management and Research(27)

Publications278 total

Integrated Aerobic Exercise and Multisensory Environment Training for Age-related Cognitive Decline via Hippocampal-prefrontal Neural Circuit Modulation
Molecular Neurobiology·2025
Efficacy and safety of bi‐weekly cofrogliptin treatment replacing daily dipeptidyl peptidase‐4 inhibitors in Chinese patients with type 2 diabetes mellitus: A multicenter, open‐label, randomized controlled phase 2 trial
Diabetes Obesity and Metabolism·2025Open Access
Author response for "Efficacy and safety of bi-weekly cofrogliptin treatment replacing daily dipeptidyl peptidase-4 inhibitors in Chinese patients with type 2 diabetes mellitus: A multicenter, open-label, randomized controlled phase 2 trial"
2025
βeta-2 glycoprotein I is a novel regulator of Apolipoprotein E containing HDL particles in females
Biology of Sex Differences·2025Open Access
Reduced Primary Teeth Fluorosis In Guizhou’s Endemic Areas
International Dental Journal·2025Open Access
Alterations And Occurrence Of Fluorine In Moderate Dental Fluorosis Enamel
International Dental Journal·2025Open Access
Implementation of Established Global Guidelines in the Management of CKD in Patients with Type 2 Diabetes in Asia
Clinical Journal of the American Society of Nephrology·2025· 1 cited
Effective of high-intensity interval training and moderate-intensity continuous training on body composition, glycolipid metabolism, and cardiopulmonary function in patients with pre-diabetes: a randomized controlled trial
Frontiers in Endocrinology·2025Open Access
Periodontal health status and influencing factors among 12- and 15-year-old adolescents: evidence from a cross-sectional study in Guizhou province, China (2019–2020)
BMC Oral Health·2025· 3 citedOpen Access
418P Real-world outcomes of first-line nivolumab for advanced gastric or gastroesophageal junction adenocarcinoma: A multicenter, retrospective, observational study
Annals of Oncology·2025Open Access
863-P: A Multicenter, Randomized, Open-Label, Controlled Study on Evaluating the Efficacy and Safety of Switching from Daily DPP-4 Inhibitors to Cofrogliptin in Patients with Type 2 Diabetes Mellitus in China
Diabetes·2025
OP0299 GENAKUMAB REDUCES THE RISK OF ACUTE GOUT FLARES DURING INITIATION OF URATE-LOWERING THERAPY: A PHASE 2, RANDOMIZED, OPEN-LABEL, MULTI-CENTER, ACTIVE-CONTROLLED CLINICAL TRIAL
Annals of the Rheumatic Diseases·2025· 1 citedOpen Access
Correction: Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial
Diabetologia·2025· 2 citedOpen Access
Association of Serum Total Bilirubin to Cholesterol Ratio With Progression of Chronic Kidney Disease in Patients With Type 2 Diabetes: A Retrospective Cohort Study
Journal of Diabetes·2025· 2 citedOpen Access
Corrigendum to “Protective effects of triptolide on TLR4 mediated autoimmune and inflammatory response induced myocardial fibrosis in diabetic cardiomyopathy” [J. Ethnopharmacol. 193 (2016) 333-344]
Journal of Ethnopharmacology·2025
Longitudinal Evaluation of Metabolic Benefits of Inactivated COVID-19 Vaccination in Diabetic Patients in Tianjin, China
Medical Science Monitor·2025Open Access
S-nitrosylation of peroxiredoxin 2 exacerbates hyperuricemia-induced renal injury through regulation of mitochondrial homeostasis
Free Radical Biology and Medicine·2025· 5 citedOpen Access
Endothelial AGGF1 promotes retinal angiogenesis by coordinating TNFSF12/FN14 signalling
Nature Communications·2025· 6 citedOpen Access
Population profile and glycemic control following initiation or switch of injectable therapies in Tianjin, China: A real‐world retrospective cohort study of adults with type 2 diabetes
Journal of Diabetes Investigation·2025Open Access
Corrigendum: Empagliflozin alleviates hepatic steatosis by activating the AMPK-TET2-autophagy pathway in vivo and in vitro
Frontiers in Pharmacology·2025· 1 citedOpen Access
page 1 of 14Next →

Frequent Co-authors

Bei Sun(19), Mei Xue(11), Ying Cheng(9), Chunjun Li(9), Yunpeng Chang(8), Yunhong Lu(7), Fei Han(6), Xiaochen Yu(6), Liping Han(6), Zejun Ma(6), Baocheng Chang(6), Wenyan Niu(5), Linxin Xu(4), Yishuang Duan(4), Xiaoyu Li(4), Linong Ji(3), Xiaoyu Li(3), Zhe Han(3), Ziyu Meng(3), Chaofei Xu(3)